Drug intelligence / Profile preview

Bronchine

Development stage: Unknown
Lead developer: Ankh Pharmaceuticals
Administration: Oral

Overview

Bronchine is an herbal dietary supplement developed and marketed by Ankh Pharmaceuticals. It is positioned as a wellness product for respiratory support and bronchial health. As a multi-ingredient Ayurvedic-inspired formulation, it is sold directly to consumers and is not a regulated pharmaceutical drug candidate undergoing traditional clinical trial phases. The product is part of a broader portfolio of herbal supplements targeting various health areas such as immunity, digestion, and joint pain.

Brand names: Bronchine
Other names: Bronchine

Beyond the preview

Go deeper on Bronchine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bronchine.

Explore the full profile